Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Personalized ovarian cancer vaccines spark immunity in phase 1 trial

Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these neoantigens and prevent cancer from returning after treatment.

Personalized ovarian cancer vaccines spark immunity in phase 1 trial

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Wednesday 28 October →